Skip to main content
Genome&Company logo

Genome&Company — Investor Relations & Filings

Ticker · 314130 ISIN · KR7314130006 KO Manufacturing
Open in API
Filings indexed 427 across all filing types
Latest filing 2019-01-02 Major Shareholding Noti…
Country KR South Korea
Listing KO 314130

About Genome&Company

http://genomecom.co.kr/

Genome&Company is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapeutics. The company's research and development pipeline is centered on two primary platforms: microbiome-based pharmaceuticals and novel immune checkpoint inhibitors for immuno-oncology. Its drug candidates are derived from its proprietary microbiome platform and are aimed at treating a range of diseases, with a significant focus on cancer. In addition to its pharmaceutical programs, the company develops and markets consumer healthcare products, including dietary supplements and cosmeceuticals, leveraging its expertise in microbes and probiotics.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares by Premier Partners (and its related fund) in the company 'Genome & Company' (지놈앤컴퍼니) due to a new listing on the KONEX market. This document type is specifically used to notify the market of significant share ownership changes (crossing the 5% threshold), which falls under the 'Major Shareholding Notification' category.
2019-01-02 Korean
사업보고서 (2017.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for Genome & Company (주식회사 지놈앤컴퍼니) for the fiscal years 2016 and 2017. It includes the independent auditor's report, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. It is a comprehensive financial document prepared by an external accounting firm (태성회계법인) and is not an announcement or a summary, thus it fits the 'Audit Report' category. FY 2017
2018-12-31 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares by DSC Investment and its related funds due to a new listing on the KONEX exchange. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) as it tracks significant ownership thresholds.
2018-12-31 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/KRX). This type of filing is a standard regulatory requirement for insiders or major shareholders to disclose their holdings and changes in ownership. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers insider trades and ownership reporting by directors and major shareholders.
2018-12-31 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details the acquisition of shares by '한국투자 글로벌 제약산업 육성 사모투자전문회사' in '(주)지놈앤컴퍼니'. This type of filing is specifically used to notify the market when an entity crosses a significant shareholding threshold (in this case, 11.95%). According to the provided definitions, this falls under 'Major Shareholding Notification'.
2018-12-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서), which is a standard regulatory filing in South Korea (DART system) used to disclose changes in shareholdings by major shareholders or insiders. This falls under the category of Major Shareholding Notification (MRQ) as it details the ownership percentage and changes in holdings for a major shareholder.
2018-12-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.